These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 32668062)

  • 1. Severe acute respiratory syndrome coronavirus 2 may be an underappreciated pathogen of the central nervous system.
    Alam SB; Willows S; Kulka M; Sandhu JK
    Eur J Neurol; 2020 Nov; 27(11):2348-2360. PubMed ID: 32668062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe Acute Respiratory Syndrome Coronavirus 2 Impact on the Central Nervous System: Are Astrocytes and Microglia Main Players or Merely Bystanders?
    Murta V; Villarreal A; Ramos AJ
    ASN Neuro; 2020; 12():1759091420954960. PubMed ID: 32878468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurological manifestations of SARS-CoV-2: complexity, mechanism and associated disorders.
    Tyagi K; Rai P; Gautam A; Kaur H; Kapoor S; Suttee A; Jaiswal PK; Sharma A; Singh G; Barnwal RP
    Eur J Med Res; 2023 Aug; 28(1):307. PubMed ID: 37649125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 and Long COVID: Disruption of the Neurovascular Unit, Blood-Brain Barrier, and Tight Junctions.
    Kempuraj D; Aenlle KK; Cohen J; Mathew A; Isler D; Pangeni RP; Nathanson L; Theoharides TC; Klimas NG
    Neuroscientist; 2024 Aug; 30(4):421-439. PubMed ID: 37694571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe acute respiratory syndrome coronavirus 2 infection reaches the human nervous system: How?
    Uversky VN; Elrashdy F; Aljadawi A; Ali SM; Khan RH; Redwan EM
    J Neurosci Res; 2021 Mar; 99(3):750-777. PubMed ID: 33217763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does coronaviruses induce neurodegenerative diseases? A systematic review on the neurotropism and neuroinvasion of SARS-CoV-2.
    ElBini Dhouib I
    Drug Discov Ther; 2021 Jan; 14(6):262-272. PubMed ID: 33390561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of SARS-CoV-2 with the Blood-Brain Barrier.
    Erickson MA; Rhea EM; Knopp RC; Banks WA
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19-Associated Neurological Disorders: The Potential Route of CNS Invasion and Blood-Brain Relevance.
    Achar A; Ghosh C
    Cells; 2020 Oct; 9(11):. PubMed ID: 33120941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can Covid-19 attack our nervous system?
    Abdel Hafez SMN
    J Chem Neuroanat; 2021 Nov; 117():102006. PubMed ID: 34324964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential mechanism of SARS-CoV-2-associated central and peripheral nervous system impairment.
    Zhang Y; Chen X; Jia L; Zhang Y
    Acta Neurol Scand; 2022 Sep; 146(3):225-236. PubMed ID: 35699161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 and cognitive impairment: neuroinvasive and blood‒brain barrier dysfunction.
    Chen Y; Yang W; Chen F; Cui L
    J Neuroinflammation; 2022 Sep; 19(1):222. PubMed ID: 36071466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurological Complications Associated with the Blood-Brain Barrier Damage Induced by the Inflammatory Response During SARS-CoV-2 Infection.
    Alquisiras-Burgos I; Peralta-Arrieta I; Alonso-Palomares LA; Zacapala-Gómez AE; Salmerón-Bárcenas EG; Aguilera P
    Mol Neurobiol; 2021 Feb; 58(2):520-535. PubMed ID: 32978729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central nervous system as a target of novel coronavirus infections: Potential routes of entry and pathogenic mechanisms.
    Sharma S; Jagadeesh H; Saxena A; Chakravarthy H; Devanathan V
    J Biosci; 2021; 46(4):. PubMed ID: 34840148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurological pathophysiology of SARS-CoV-2 and pandemic potential RNA viruses: a comparative analysis.
    Chakravarty N; Senthilnathan T; Paiola S; Gyani P; Castillo Cario S; Urena E; Jeysankar A; Jeysankar P; Ignatius Irudayam J; Natesan Subramanian S; Lavretsky H; Joshi S; Garcia G; Ramaiah A; Arumugaswami V
    FEBS Lett; 2021 Dec; 595(23):2854-2871. PubMed ID: 34757622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 journey to the brain with a focus on potential role of docosahexaenoic acid bioactive lipid mediators.
    Hachem M
    Biochimie; 2021 May; 184():95-103. PubMed ID: 33639198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
    Yachou Y; El Idrissi A; Belapasov V; Ait Benali S
    Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroinvasion of SARS-CoV-2 may play a role in the breakdown of the respiratory center of the brain.
    Dey J; Alam MT; Chandra S; Gupta J; Ray U; Srivastava AK; Tripathi PP
    J Med Virol; 2021 Mar; 93(3):1296-1303. PubMed ID: 32964419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of aging in Blood-Brain Barrier dysfunction and susceptibility to SARS-CoV-2 infection: impacts on neurological symptoms of COVID-19.
    Adesse D; Gladulich L; Alvarez-Rosa L; Siqueira M; Marcos AC; Heider M; Motta CS; Torices S; Toborek M; Stipursky J
    Fluids Barriers CNS; 2022 Aug; 19(1):63. PubMed ID: 35982454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of central nervous system infection and neuroinvasive routes, as well as neurological involvement, in the lethality of SARS-CoV-2 infection.
    Liu JM; Tan BH; Wu S; Gui Y; Suo JL; Li YC
    J Med Virol; 2021 Mar; 93(3):1304-1313. PubMed ID: 33002209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.